Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Revenue (2016 - 2024)

vTv Therapeutics (VTVT) has disclosed Revenue for 10 consecutive years, with $17000.0 as the latest value for Q4 2024.

  • Quarterly Revenue changed N/A to $17000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $17000.0 through Sep 2025, down 98.3% year-over-year, with the annual reading at $1.0 million for FY2024, N/A changed from the prior year.
  • Revenue hit $17000.0 in Q4 2024 for vTv Therapeutics, down from $1.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $6.4 million in Q4 2020 to a low of $7000.0 in Q3 2020.
  • Historically, Revenue has averaged $1.1 million across 4 years, with a median of $13000.0 in 2021.
  • Biggest five-year swings in Revenue: surged 91314.29% in 2020 and later crashed 99.86% in 2021.
  • Year by year, Revenue stood at $6.4 million in 2020, then plummeted by 99.86% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022, then soared by 88.89% to $17000.0 in 2024.
  • Business Quant data shows Revenue for VTVT at $17000.0 in Q4 2024, $1.0 million in Q1 2024, and $9000.0 in Q4 2022.